Blossomhill Therapeutics, Inc. (BLSM)

13.94 -1.04 (-6.94%) USD  |  NASDAQ  |  Oct 16, 16:00
14.03 +0.09 (+0.65%) After-Hours: 20:00
More

Blossomhill Therapeutics EPS Diluted (Quarterly) : -0.7475 for June 30, 2026

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2025. Start Trial.
Date Value
June 30, 2026 -0.7475
March 31, 2026 -0.6609
Date Value
June 30, 2025 -0.4167
March 31, 2025 -0.3296

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
IGC Pharma, Inc. -0.0293
Cocrystal Pharma, Inc. -0.2295
CNBX Pharmaceuticals, Inc. -0.0001
Arvinas, Inc. 2.578
Fulcrum Therapeutics, Inc. -0.3433

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -23.76M
Total Expenses (Quarterly) 23.76M
Enterprise Value 627.90M
Earnings Yield -15.46%
Normalized Earnings Yield -15.46